MedTrace Logo

The Effect Of Dual Treatment With L-Carnitine And Magnesium On Fatty Liver

NCT01956825 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2013-10-08

No results posted yet for this study

Summary

The purpose of this study is to determine whether the dual therapy of the amino acid L-CARNITINE and magnesium have an effect on reducing the liver fat content in patients with non alcoholic fatty liver disease (NAFLD).

Conditions

  • Non Alcoholic Fatty Liver Disease

Interventions

DIETARY_SUPPLEMENT

"slim water"

Sponsors & Collaborators

  • Meir Medical Center

    lead OTHER

Principal Investigators

  • DAN FELDMAN, MD · Meir Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2014-04-30
Completion
2014-04-30

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01956825 on ClinicalTrials.gov